UNAUDITED SUMMARIZED QUARTERLY FINANCIAL INFORMATION

12 Months Ended

Dec. 31, 2014

Quarterly Financial Information [Abstract]

UNAUDITED SUMMARIZED QUARTERLY FINANCIAL INFORMATION

14. UNAUDITED SUMMARIZED QUARTERLY FINANCIAL INFORMATION
						Net Income (Loss) Attributable to Amedisys, Inc. Common Stockholders (1)
		Revenue		Net Income (Loss) Attributable to Amedisys, Inc.		Basic		Diluted
	2014:
	1st Quarter (2) (3)	$	298.7	$	(12.4)	$	(0.39)	$	(0.39)
	2nd Quarter (4) (5) (6)		305.0		7.6		0.24		0.23
	3rd Quarter (6) (7)		300.3		8.4		0.26		0.26
	4th Quarter (2)		300.5		9.1		0.28		0.28
		$	1,204.5	$	12.8	$	0.39	$	0.39
	2013:
	1st Quarter (8)	$	328.6	$	2.7	$	0.09	$	0.09
	2nd Quarter (8) (9)		315.9		1.8		0.06		0.06
	3rd Quarter (8) (9) (10)		301.3		(91.1)		(2.89)		(2.89)
	4th Quarter (8) (9)		303.5		(9.6)		(0.30)		(0.30)
		$	1,249.3	$	(96.2)	$	(3.08)	$	(3.08)

• Because of the method used in calculating per share data, the quarterly per share data may not necessarily total to the per share data as computed for the entire year.
• During the first and fourth quarters of 2014, we recognized non-cash other intangibles impairment charges of $1.4 million and $0.6 million, net of income taxes.
• During the first quarter of 2014, we recorded charges for the accrual of various relators' attorneys' fees and expenses in connection with the settlement agreement to resolve the U.S. Department of Justice investigation and the Stark Law Self-Referral matter and exit and restructuring activity costs. Net of income taxes, these charges amounted to $2.4 million and $6.1 million, respectively.
• During the second quarter of 2014, we recorded an accrual related to an OIG Self-Disclosure matter. Net of income taxes, this charge amounted to $0.9million.
• During the second quarter of 2014, we recorded a software write-off in the amount of $0.9 million, net of income taxes.
• Our results for the three months ended June 30, 2014, included a gain related to the sale of care centers in the amount of $1.3 million, net of income taxes. Our results for the three months ended September 30, 2014, included a loss related to the disposal of our in-patient facility in the amount of $0.3 million, net of income taxes.
• During the third quarter of 2014, we recorded a charge related to the write-off of deferred financing fees in the amount of $0.3 million, net of income taxes.
• During each of the four quarters of 2013, we incurred certain costs associated with the U.S. Department of Justice Civil Investigative Demand and other legal matters. Net of income taxes, these costs amounted to $1.2 million, $1.0 million, $0.6 million and $0.5 million for the three-month periods ended March 31, 2013, June 30, 2013, September 30, 2013 and December 31, 2013, respectively.
• During the second, third and fourth quarters of 2013, we recognized non-cash goodwill and other intangibles impairmentcharges of $1.4 million, $0.9 million and $3.5 million, net of income taxes.
• During the third quarter of 2013, we recorded a charge for the accrual of the U.S. Department of Justice settlement in the amount of $93.9 million, net of income taxes. Additionally, our results included proceeds received from our Directors' & Officers' insurance in the amount of $3.4 million, net of income taxes.